Clinical Study

Clinical Characteristics of Endogenous Cushing’s Syndrome at a Medical Center in Southern Taiwan

Table 2

Test results for ACTH-independent CS and ACTH-dependent Cushing’s syndrome (CS) in the 84 patients studied.

TestsACTH-independent CS% (number of patients)ACTH-dependent CS% (number of patients)All patients with CS% (number of patients)Cushing's disease% (number of patients) Ectopic CS% (number of patients)

Loss of cortisol circadian
 rhythm (+)*96.4% (53/55) 94.4% (17/18)95.9% (70/73)
Baseline plasma cortisol levels
 at 1600–2200 h > 7.5 μg/dL98.3% (58/59) 94.4% (17/18)97.4% (75/77)
Baseline 24 h UFC
 >122 μg/24 h87.5% (35/40) 91.7% (11/12)88.5% (46/52)
 >80 μg/24 h97.5% (39/40) 91.7% (11/12)96.2% (50/52)
Overnight LDDST**
 0800 h plasma cortisol > 5 μg/dL: nonsuppression100% (48/48) 88.9% (8/9)98.2% (56/57)85.7% (6/7)100% (2/2)
2-day
 0800 h plasma cortisol > 5 μg/dL: nonsuppression100% (25/25) 100% (7/7)100% (32/32)100% (5/5)100% (2/2)
 24 h UFC > 122 μg/day: nonsuppression100% (15/15) 66.7% (2/3)94.4% (17/18)50% (1/2)100% (1/1)
2-day
 0800 h plasma cortisol
  Nonsuppression95.5% (42/44)55.6% (5/9)100% (2/2)
  Suppression4.5% (2/44)44.4% (4/9)
24 h UFC
  Nonsuppression88.9% (24/27)14.3% (1/7)100% (1/1)
  Suppression11.5% (3/26)85.7% (6/7)

Loss of cortisol circadian rhythm (+): baseline plasma cortisol levels at 1600–2200 h greater than 7.5 μg/dL and greater than 50% of baseline plasma cortisol levels at 0800–0900 h.
Overnight LDDST: overnight low-dose dexamethasone suppression test: dexamethasone 1 mg orally at 2300 h and blood sampling for cortisol the following morning at 0800 h.
2-day LDDST: 2-day low-dose dexamethasone suppression test: dexamethasone 0.5 mg orally every 6 hours for a total of 8 doses and blood sampling for cortisol at 0800 h on the third day of testing. Collection of urine for free cortisol for 24 h from 0800 h on the second day to 0800 h on third day following dexamethasone administration.
2-day HDDST: 2-day high-dose dexamethasone suppression test: dexamethasone 2 mg orally every 6 hours for a total of 8 doses and blood sampling for cortisol at 0800 h on the third day of testing. Collection of urine for free cortisol for 24 h from 0800 h on the second day to 0800 h on the third day following dexamethasone administration.
Nonsuppression of 0800 h plasma cortisol on 2-day HDDST: a cut-off value of 0800 h plasma cortisol after 2-day HDDST is greater than 50% of baseline plasma cortisol.
Nonsuppression of 24 h urine free cortisol on 2-day HDDST: a cut-off value of 24 h urinary free cortisol after 2-day HDDST is greater than 50% of baseline 24 h urinary free cortisol.